| Business Summary | | SpectraScience,
Inc.
is
focused
on
developing
the
Optical
Biopsy
System,
which
is
a
proprietary,
minimally
invasive
spectroscopic
system
that
optically
scans
tissue
in
real-time
to
distinguish
between
normal
and
pre-cancerous
or
cancerous
tissue
without
the
need
to
remove
tissue
from
the
body.
This
product
is
used
during
endoscopy
of
the
colon
when
screening
for
colon
cancer.
The
Optical
Biopsy
System
allows
the
endoscopist
to
distinguish
in
real-time
whether
colon
tissue
is
normal,
as
opposed
to
pre-cancerous
or
cancerous,
by
optically
scanning
tissue
with
an
optical
fiber
and
obtaining
an
instant
analysis. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | SpectraScience
designs,
develops,
manufactures
and
markets
medical
products
and
computer
products
used
for
minimally-invasive
spectroscopic
systems
to
facilitate
the
detection
of
canceous
tissue.
For
the
six
months
ended
6/30/01,
the
Company
reports
no
revenues.
Net
loss
rose
43%
to
$1.7
million.
Higher
loss
reflects
increased
expenses
related
to
clinical
studies
and
the
development
of
next
generation
products. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Chester Sievert, Jr., 49 Chairman,
Pres, CEO, Sec. | $216K | Scott Anderson, 46 VP
of Marketing and Sales | 167K | Ruth Bryan, 38 Financial
Officer | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|